Tolerance and desensitization in experimental eczema.
D000818:Animals; D000831:Animals, Newborn; D001152:Arsenicals / Q000494:pharmacology; D001557:Benzenesulfonates / Q000008:administration & dosage; D002713:Chlorine / Q000008:administration & dosage; D002840:Chromates / Q000008:administration & dosage; D003877:Dermatitis, Contact / Q000517:prevention & control*; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000209:etiology; D004485:Eczema / Q000517:prevention & control*; D005260:Female; D005620:Freund's Adjuvant; D006241:Haptens / Q000008:administration & dosage; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000517:prevention & control*; D007108:Immune Tolerance / Q000187:drug effects*; D008214:Lymphocytes / Q000276:immunology; D008431:Maternal-Fetal Exchange; D009578:Nitrobenzenes / Q000008:administration & dosage; D010853:Picryl Chloride / Q000494:pharmacology; D011247:Pregnancy; D013997:Time Factors
D001152:Arsenicals; D001557:Benzenesulfonates; D002840:Chromates; D006241:Haptens; D009578:Nitrobenzenes; D002713:Chlorine; D005620:Freund's Adjuvant; D010853:Picryl Chloride